Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC)’.
The above information is a part of company’s filings submitted to BSE.